





BACTERIOCINS are ribosomally‐synthesized antimicrobial peptides produced by
bacteria. Most LAB bacteriocins are pore formers but some are also active as cell
wall inhibitors by targeting cell wall precursors. GOALS
Lcn972 is a bacteriocin that inhibits cell wall biosynthesis at the division septum by
binding to lipid II. It is active exclusively against other lactococci and lacks any
post‐translational modifications. These features make Lcn972 an attractive
molecule as template for developing new antibiotics as it may bear a new lipid II
binding domain. Unfortunately Lcn972 unfolds irreversible at room temperature
preventing its use to map the interactions with lipid II.
? To solve the 3D structure of Lcn972 by NMR
? To introduce disulfide bridges to prevent Lcn972
unfolding
Lcn972 variants
Cys codons were introduced by inverse PCR on the nisin‐inducible lcn972 expressing
plasmid pBL54 and the mutated plasmids were introduced into L. lactis NZ9000. Inhibitory
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nm) at 37 °C. Unfolding was partially prevented in N30CA59C and delayed in S15CA26C.  





























‐ DTT + DTT
Glycerol preserves the folded active form
of Lcn972


























































?Covalent linking of both halves of the β‐sandwich slows down unfolding but impairs activity.
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